Bulletin 2009/07 - European Patent Office
Bulletin 2009/07 - European Patent Office
Bulletin 2009/07 - European Patent Office
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
(A61K) II.1(1)<br />
(25) En (26) En<br />
(21) 99957825.5 (22) 16.12.1999<br />
(84) AT BE CH CY DE DK ES FI FR GB GR IE IT LI<br />
LU MC NL PT SE<br />
AL LT LV MK RO SI<br />
(43) 10.10.2001<br />
(86) CA 1999/001194 16.12.1999<br />
(87) WO 2000/035481 2000/25 22.06.2000<br />
(30) 17.12.1998 US 213770<br />
(54) • MULTIVALENTE IMMUNOGENISCHE<br />
ZUSAMMENSETZUNG, DIE EINE RSV<br />
UNTEREINHEIT ZUSAMMENSETZUNG<br />
UND EIN INFLUENZAVIRUS PRÄPARAT<br />
ENTHÄLT<br />
• MULTIVALENT IMMUNOGENIC COMPOSI-<br />
TION CONTAINING RSV SUBUNIT COM-<br />
POSITION AND INFLUENZA VIRUS<br />
PREPARATION<br />
• COMPOSITION IMMUNOGENE POLYVA-<br />
LENTE CONTENANT UNE COMPOSITION<br />
DE SOUS-UNITE DE RSV ET UNE PREPA-<br />
RATION D'INFLUENZAVIRUS<br />
(73) Sanofi Pasteur Limited, 1755 Steeles Avenue<br />
West, Toronto, Ontario M2R 3T4, CA<br />
(72) CATES, George, A., Richmond Hill, Ontario<br />
L4C 3T5, CA<br />
SAMBHARA, Suryaprakash, Markham,<br />
Ontario L3S 1Y1, CA<br />
BURT, David, Ajax, Ontario L1T 2S2, CA<br />
KLEIN, Michel, H., Willowdale, Ontario M2P<br />
1B9, CA<br />
(74) Lawrence, Malcolm Graham, et al,<br />
HLBBshaw Merlin House Falconry Court<br />
Baker's Lane, Epping, Essex CM16 5DQ, GB<br />
(51) A61K 39/295 (11) 1 409 012 B1<br />
C12N 15/861 A61K 39/235<br />
(25) En (26) En<br />
(21) 02780874.0 (22) 13.05.2002<br />
(84) AT BE CH CY DE DK ES FI FR GB GR IE IT LI<br />
LU MC NL PT SE TR<br />
SI<br />
(43) 21.04.2004<br />
(86) US 2002/015239 13.05.2002<br />
(87) WO 2003/000283 2003/01 03.01.2003<br />
(30) 22.06.2001 US 300131 P<br />
12.<strong>07</strong>.2001 US 304843 P<br />
(54) • VERFAHREN ZUR AUSLÖSUNG EINER<br />
ZYTOTOXISCHEN IMMUNANTWORT UND<br />
DAFÜR NÜTZLICHE REKOMBINANTE<br />
AFFEN-ADENOVIRUS-ZUSAMMENSET-<br />
ZUNGEN<br />
• METHODS OF INDUCING A CYTOTOXIC<br />
IMMUNE RESPONSE AND RECOMBINANT<br />
SIMIAN ADENOVIRUS COMPOSITIONS<br />
USEFUL THEREIN<br />
• PROCEDES VISANT A INDUIRE UNE<br />
REACTION IMMUNITAIRE CYTOTOXIQUE<br />
ET COMPOSITIONS D'ADENOVIRUS<br />
SIMIEN RECOMBINE UTILES A CET EFFET<br />
(73) THE WISTAR INSTITUTE OF ANATOMY AND<br />
BIOLOGY, 3601 Spruce Street, Philadelpia,<br />
PA 19104-4268, US<br />
The Trustees of The University of Pennsylvania,<br />
3160 Chestnut Street, Suite 200,<br />
Philadelphia, Pennsylvania 19104-6283, US<br />
(72) ERTL, Hildegund, C., J., Villanova, PA 19085,<br />
US<br />
WILSON, James, M., Gladwyne, PA 19035,<br />
US<br />
(74) Manaton, Ross Timothy, et al, Bromhead<br />
Johnson 19 Buckingham Street, London<br />
WC2 6EF, GB<br />
(51) A61K 39/385 (11) 1 487 484 B1<br />
A61K 39/29 A61K 39/21<br />
C<strong>07</strong>K 14/18 A61P 31/00<br />
A61P 35/00<br />
Europäisches <strong>Patent</strong>blatt<br />
<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />
<strong>Bulletin</strong> européen des brevets<br />
(25) Fr (26) Fr<br />
(21) 03727589.8 (22) 14.03.2003<br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HU IE IT LI LU MC NL PT RO SE SI SK<br />
TR<br />
(43) 22.12.2004<br />
(86) FR 2003/000821 14.03.2003<br />
(87) WO 2003/<strong>07</strong>5956 2003/38 18.09.2003<br />
(30) 14.03.2002 FR 0203189<br />
(54) • VERWENDUNG VON MISCHUNGEN VON<br />
LIPOPEPTIDEN ZUR BEREITUNG VON<br />
IMPFSTOFFEN<br />
• USE OF MIXTURES OF LIPOPEPTIDES FOR<br />
VACCINE PRODUCTION<br />
• UTILISATION DE MELANGES DE LIPO-<br />
PEPTIDES POUR LA FABRICATION DE<br />
VACCINS<br />
(73) CENTRE NATIONAL DE LA RECHERCHE<br />
SCIENTIFIQUE (CNRS), 3, rue Michel-Ange,<br />
75016 Paris, FR<br />
UNIVERSITE DE LILLE II, 42, Rue Paul-Duez,<br />
59800 Lille, FR<br />
INSTITUT NATIONAL DE LA SANTE ET DE<br />
LA RECHERCHE MEDICALE (INSERM), 101,<br />
rue de Tolbiac, 75013 Paris, FR<br />
(72) GUILLET, Jean-Gérard, F-75009 Paris, FR<br />
BOURGAULT-VILLADA, Isabelle, F-750<strong>07</strong><br />
Paris, FR<br />
DUPUIS, Marion, F-75012 Paris, FR<br />
GRAS MASSE, Hélène, F-59710 Merignies,<br />
FR<br />
BOUREL, Line, F-59000 Lille, FR<br />
MELNYK, Oleg, F-59112 Annoeulin, FR<br />
JOLY, Pascal, F-59000 Lille, FR<br />
BONNET, Dominique, F-59000 Lille, FR<br />
MALINGUE, Frédéric, F-59800 Lille, FR<br />
GRAND JEAN, Cyrille, F-75013 Paris, FR<br />
GEORGES, Bertrand, F-59221 BAUVIN, FR<br />
(74) Hirsch & Associés, 58, avenue Marceau,<br />
75008 Paris, FR<br />
(51) A61K 39/39 (11) 1 748 792 B1<br />
A61K 31/70 A61P 35/00<br />
(25) En (26) En<br />
(21) 05750379.9 (22) 26.05.2005<br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HU IE IS IT LI LT LU MC NL PL PT RO SE<br />
SI SK TR<br />
(43) <strong>07</strong>.02.20<strong>07</strong><br />
(86) IB 2005/001827 26.05.2005<br />
(87) WO 2005/115450 2005/49 08.12.2005<br />
(30) 26.05.2004 US 574638 P<br />
24.06.2004 US 582455 P<br />
26.05.2005 US 138171<br />
(54) • ZUSAMMENSETZUNGEN AUS DEMETHY-<br />
LIERENDEN MITTELN ALS VERSTÄRKER<br />
DER IMMUNTHERAPIE ZUR BEHANL-<br />
DUNG VON CHRONISCHEN INFEKTIONEN<br />
UND NEOPLASTISCHEN ERKRANKUNGEN<br />
UND BEHANDLUNGSVERFAHREN DAFÜR<br />
• COMPOSITIONS COMPRISING DEMETHY-<br />
LATING AGENTS AS ENHANCERS OF<br />
IMMUNOTHERAPY FOR THE TREATMENT<br />
OF CHRONIC INFECTIONS AND NEO-<br />
PLASTIC DISEASES AND METHODS FOR<br />
TREATING THE SAME<br />
• COMPOSITIONS COMPRENANT DES<br />
AGENTS DEMETHYLISANTS RENFOR-<br />
ÇANT L'IMMUNOTHERAPIE DANS LE<br />
TRAITEMENT D'INFECTIONS CHRONI-<br />
QUES ET DE MALADIES NEOPLASTIQUES,<br />
ET PROCEDE DE TRAITEMENT ASSOCIE<br />
(73) Biovaxim Limited, Finsgate, 5-7 Cranwood<br />
Street London EC1V 9EE, GB<br />
(72) ANDRIEU, Jean-Marie, F-75005 Paris, FR<br />
WEI-LU, Louis, F-75015 Paris, FR<br />
(74) Breese, Pierre, BREDEMA 38, avenue de<br />
l'Opéra, 75002 Paris, FR<br />
514<br />
<strong>Patent</strong>e<br />
<strong>Patent</strong>s<br />
Brevets (<strong>07</strong>/<strong>2009</strong>) 11.02.<strong>2009</strong><br />
(51) A61K 39/395 (11) 1 109 577 B1<br />
A61K 39/00 C<strong>07</strong>K 14/00<br />
C<strong>07</strong>K 16/00 A61K 39/40<br />
(25) En (26) En<br />
(21) 99942533.3 (22) 31.08.1999<br />
(84) AT BE CH CY DE DK ES FI FR GB GR IE IT LI<br />
LU MC NL PT SE<br />
(43) 27.06.2001<br />
(86) US 1999/019727 31.08.1999<br />
(87) WO 2000/012131 2000/10 09.03.2000<br />
(30) 31.08.1998 US 98439 P<br />
(54) • Multikomponenten Impfstoffe gegen Staphylococcus<br />
aureus<br />
• Multicomponent vaccines against Staphylococcus<br />
aureus<br />
• Vaccins à plusieurs constituants contre<br />
Straphylococcus aureus<br />
(73) Inhibitex, Inc., 8995 Westside Parkway,<br />
Alpharetta,GA 30004, US<br />
THE TEXAS A&M UNIVERSITY SYSTEM, 310<br />
Wisenbaker Building, Mail Stop 3369, College<br />
Station, TX 77843-3369, US<br />
The Provost Fellows and Scholars of the<br />
College of the Holy and Undivided Trinity of<br />
Queen Elizabeth Near Dublin, Trinity College,<br />
Dublin 2, IE<br />
(72) PATTI, Joseph, M., Cummings, GA 30040,<br />
US<br />
FOSTER, Timothy J., Dublin 16, IE<br />
HOOK, Magnus, Houston, TX 77005, US<br />
(74) Cripps, Joanna Elizabeth, et al, Mewburn<br />
Ellis LLP 33 Gutter Lane, London EC2V 8AS,<br />
GB<br />
A61K 39/40 → (51) A61K 39/395<br />
(51) A61K 47/48 (11) 1 757 311 B1<br />
C<strong>07</strong>K 7/08 C<strong>07</strong>K 14/00<br />
C<strong>07</strong>K 16/22 C<strong>07</strong>K 16/24<br />
C<strong>07</strong>K 16/46<br />
(25) En (26) En<br />
(21) 06017276.4 (22) 22.12.2000<br />
(84) AT BE CH CY DE DK ES FI FR GB GR IE IT LI<br />
LU MC NL PT SE TR<br />
(43) 28.02.20<strong>07</strong><br />
(30) 24.12.1999 US 173048 P<br />
(54) • Verfahren und Zusammensetzungen zur<br />
Verlängerung der Entsorgungshalbwertszeit<br />
von biowirksamen Verbindungen<br />
• Methods and compositions for prolonging<br />
elimination half-times of bioactive compounds<br />
• Méthodes et compositions pour la prolongation<br />
de la demi-période d'élimination de<br />
composés bioactifs<br />
(73) Genentech, Inc., 1 DNA Way, South San<br />
Francisco CA 94080-4990, US<br />
(72) Delano, Warren, San Carlos, CA 94<strong>07</strong>0, US<br />
Dennis, Mark, S., San Carlos, CA 94<strong>07</strong>0, US<br />
Lowman, Henry B., El Granada, CA 94018,<br />
US<br />
(74) Walton, Seán Malcolm, et al, Mewburn Ellis<br />
LLP 33 Gutter Lane, London EC2V 8AS, GB<br />
(62) 00988373.7 / 1 240 337<br />
A61K 48/00 → (51) C12N 15/63<br />
A61K 49/00 → (51) C<strong>07</strong>K 14/705<br />
A61K 49/00 → (51) C12Q 1/02<br />
A61K 49/20 → (51) A61B 5/055<br />
(51) A61L 2/025 (11) 1 835 940 B1<br />
A23L 3/30<br />
B65B 55/04<br />
B01J 19/10<br />
(25) En (26) En<br />
(21) 05826151.2 (22) 02.12.2005
Change language